Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTekCapital Regulatory News (TEK)

Share Price Information for TekCapital (TEK)

Share Price is delayed by 15 minutes
Get Live Data
5.80    -0.10 (-1.69%)
Bid:
5.70
Ask:
5.90
Spread: 0.20 (3.509%)
Market Cap: £14.92m
TEK Live PriceLast checked at - London Stock Exchange

Intraday TekCapital Share Chart

Executive Appointment

9 Oct 2018 07:00

RNS Number : 3377D
Tekcapital plc
09 October 2018
 

 

Tekcapital plc

 

("Tekcapital" or the "Company")

 

Executive Appointment

Tekcapital plc, (AIM: TEK) the UK intellectual property investment group focused on creating marketplace value from university technology, announces that Dr Mireya McKee has joined as Business Development Manager.

Mireya has over 17 years of research, technology transfer and innovation management experience. She completed a Ph. D. in biochemistry from the University of Texas-Austin as a CONACYT fellow. Afterwards, she carried out postdoctoral research in nanotechnology at Oxford University, where she received an EPSRC Developing Future Leaders-Women in Science grant.

She transitioned into business, completing a certification program on the commercialization of scientific research at Oxford's Saïd Business School. Dr McKee also served as a senior consultant in technology transfer for Oxford University Innovation (OUI).

Mireya founded an innovation management consultancy that provided training and support to universities and start-up companies around the globe. As part of this effort, she has become knowledgeable about the innovation ecosystems of Latin American countries where she has assisted a number of government agencies in designing and implementing innovation policies and programs.

Clifford M. Gross Ph.D., Chief Executive Officer of Tekcapital plc commented:

"We are enthusiastic to have Dr McKee join our team and we are confident she will help to expand our service business in Latin America."

For further information, please contact:

 

Tekcapital plc

Clifford M Gross, Ph.D.

 

Via Walbrook PR

finnCap Ltd (Nominated Adviser and Joint Broker)

 +44 (0) 20 7220 0500

Geoff Nash (Corporate Finance)

Max Bullen-Smith (Corporate Finance)

Camille Gochez (ECM)

 

Novum Securities (Joint Broker)

Colin Rowbury

 

+44 (0) 29 7399 9427

 

Walbrook PR Ltd

 +44 (0) 20 7933 8780

Paul Cornelius / Nick Rome / Sam Allen

 tekcapital@walbrookpr.com

 

Tekcapital plc - The World's Largest University Network for Open Innovation

Tekcapital's objective is to create value from investing in new, university-developed intellectual properties. Additionally, using its proprietary discovery search engine, linked to 4,500+ universities in 160 countries, coupled with expert scientific review, Tekcapital provides a range of IP investment services to make it easy for organisations to find, evaluate, acquire and license university-developed technology. Tekcapital plc is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in Oxford, in the UK. For more information, please visit www.tekcapital.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRAEVLFBVBFZFBX
Date   Source Headline
5th Apr 20193:12 pmRNSResult of AGM
2nd Apr 20197:00 amRNSStrategic Alliance Agreement with Emprende UP
1st Apr 20197:00 amRNSPortfolio Company Update
25th Mar 20197:00 amRNSPortfolio Company Update
25th Mar 20197:00 amRNSAttendance at UK Investor Show
14th Mar 20197:00 amRNSPosting of Annual Report and Notice of AGM
14th Mar 20197:00 amRNSInvestor conference call
1st Mar 20195:26 pmRNSHolding(s) in Company
26th Feb 20197:00 amRNSUpdate of Research Coverage
26th Feb 20197:00 amRNSNotice of Investor Conference Call
25th Feb 20197:00 amRNSFull Year 2018 Preliminary Results
21st Feb 20197:00 amRNSLucyd Provides Market Update
21st Feb 20197:00 amRNSNotice of Preliminary Results Announcement
19th Feb 20198:52 amRNSBelluscura Files Additional Patent
15th Feb 20193:26 pmRNSHolding(s) in Company
30th Jan 20199:23 amRNSHolding(s) in Company
14th Jan 20197:00 amRNSGuident Ltd Appoints Director
17th Dec 20184:36 pmRNSHolding(s) in Company
12th Dec 20187:00 amRNSUniversity IP webinar
6th Dec 20187:00 amRNSGuident Ltd Appoints Director
3rd Dec 20187:00 amRNSLucyd Signs R Sherman as Chief Brand Officer
26th Nov 20187:00 amRNSMello London
14th Nov 20187:00 amRNSLucyd Launches Affiliate and Reseller Program
8th Nov 201811:34 amRNSHolding(s) in Company
19th Oct 20181:52 pmRNSHolding(s) in Company
18th Oct 20185:25 pmRNSHolding(s) in Company
16th Oct 20185:02 pmRNSHolding(s) in Company
15th Oct 20187:00 amRNSPortfolio Company Update
9th Oct 20187:00 amRNSExecutive Appointment
5th Oct 20187:00 amRNSScience Advisor Appointment
3rd Oct 20187:00 amRNSPublication of Research Note
2nd Oct 20187:01 amRNSGuident Ltd Appoints Chairman
2nd Oct 20187:00 amRNSPlacing to raise approximately $1.15million
17th Sep 20187:00 amRNSBelluscura PLC Expands its Patent Portfolio
7th Sep 20187:00 amRNSAppointment of Joint Broker
21st Aug 20182:04 pmRNSHolding(s) in Company
14th Aug 20187:00 amRNSHalf-year Report
6th Aug 20187:00 amRNSMarketing & Technology Transfer Hub
3rd Aug 20187:00 amRNSLucyd Pte Ltd. Launches eShop
1st Aug 20187:00 amRNSSalarius Ltd Appoints CEO
4th Jul 20187:00 amRNSLucyd Pte Ltd. Update
29th Jun 20187:00 amRNSChange of Adviser
30th May 201812:53 pmRNSResult of Annual General Meeting
29th May 20187:00 amRNSHolding(s) in Company
22nd May 20187:00 amRNSLucyd Appoints Global Marketing Manager
22nd May 20187:00 amRNSSalarius Ltd Appoints Directors
17th May 20187:00 amRNSPrivate Placement for Belluscura plc
15th May 20181:17 pmRNSHolding(s) in Company
10th May 20187:00 amRNSHolding(s) in Company
8th May 20187:00 amRNSUniversity Technology Commercialization Programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.